GLP-1 receptor agonist trials for Type 2 diabetes

All GLP-1 receptor agonist trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying GLP-1 receptor agonist for Type 2 diabetes

• Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
  NCT06256419 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 70 Years · Sex: All (male and female) · 1 location
• Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
  NCT07309094 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 36 locations

Common questions

How many trials study GLP-1 receptor agonist for Type 2 diabetes?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.